← Eichor
Study identifier: NCT07698470 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use

Condition: Nicotine Dependence  ·  Sponsor: University of Southern California

PhaseNA
Planned participants45
Who can joinAll sexes, 21 Years to 55 Years
Healthy volunteersYes

About this study

Oral nicotine pouches (ONPs) are non-combustible nicotine products that may reduce cigarette craving and smoking cue-induced brain activity, supporting their potential as harm-reduction tools for adults who smoke cigarettes. This within-subject, repeated-measures study will evaluate the acute effects of a single 6 mg oral nicotine pouch on subjective craving and prefrontal neural responses to smoking-related cues using functional near-infrared spectroscopy (fNIRS). Participants will complete assessments before and after nicotine pouch administration following overnight nicotine abstinence to characterize changes in craving and neural cue reactivity.

This description comes directly from the study's public registry record.

Talk to the study team

USC Nicotine and Tobacco Studies  ·  213-821-0807  ·  USCONPStudy@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University of Southern California - 3641 Watt Way (HNB B22)Los Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07698470